MedDataX Logo

Success Rate of Anterior Middle Superior Alveolar (AMSA) Nerve Block in Three Different Sites of Injection

NCT ID: NCT02012257

Last Updated: 2013-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

AMSA nerve block injection is targeted anterior superior alveolar nerve and middle superior alveolar nerve branches of infraorbital nerve through nutrient canals. Therefore, central to second premolar teeth of one quadrant can be anesthetized. The aim of the present study was to evaluate the efficacy of AMSA nerve block injection at an anterior and a posterior positions compared to commonly administrated site.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

AMSA: Anterior middle superior alveolar

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia; Functional

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

anterior middle superior alveolar nerve electric pulp tester local anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anterior Site

AMSA nerve block injection

Group Type EXPERIMENTAL

AMSA nerve block injectio

Intervention Type PROCEDURE

Sites of injection

Common Site

AMSA nerve block injection

Group Type EXPERIMENTAL

AMSA nerve block injectio

Intervention Type PROCEDURE

Sites of injection

Posterior Site

AMSA nerve block injection

Group Type EXPERIMENTAL

AMSA nerve block injectio

Intervention Type PROCEDURE

Sites of injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AMSA nerve block injectio

Sites of injection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy subject
* Subjects had all their maxillary teeth from second premolar of one side to the second premolar of another Neither of these teeth was non vital, nor had large restorations, prosthetic crowns, caries, periodontal disease, history of trauma, and hypersensitivity.

Exclusion Criteria

* Use medications alleviating or altering the pain sensation
* Allergy to anesthetics Pregnancy
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shahid Beheshti University of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ali Shokraneh, DDS, MS

Ali Shokraneh

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Masoud Yaghmaei, DMD, MS

Role: STUDY_CHAIR

Shahid Beheshti University of Medical Sciences

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2952

Identifier Type: -

Identifier Source: org_study_id